Literature DB >> 27221206

Effects of vitamin D and calcium supplementation on side effects profile in patients of breast cancer treated with letrozole.

S Arul Vijaya Vani1, P H Ananthanarayanan2, D Kadambari3, K T Harichandrakumar4, R Niranjjan5, H Nandeesha2.   

Abstract

BACKGROUND: Vitamin D deficiency (<10ng/mL) and insufficiency (10-30ng/mL) may contribute to musculoskeletal symptoms observed in patients taking letrozole. This study was undertaken to assess the vitamin D status in breast cancer patients who received letrozole for >2months and to see the effects of vitamin D3 and calcium supplementation on them.
METHODS: Eighty-two breast cancer patients were included. Baseline serum 25-hydroxy vitamin D concentrations were assayed and standard questionnaire was completed. They were given vitamin D3 and calcium supplementation (2000IU/1000 mg and 4000IU/1000mg) based on their baseline serum 25-hydroxy vitamin D concentration for 12weeks.
RESULTS: Baseline serum 25-hydroxy vitamin D concentrations showed that 13.4% of patients were deficient and 73.2% of patients were insufficient in 25-hydroxy vitamin D. There was an increase in the concentrations of calcium, phosphorus and decrease in the concentrations of parathyroid hormone, alkaline phosphatase as the concentration of serum 25-hydroxy vitamin D increases. Patients who received letrozole for a longer duration had a low concentration of serum 25 (OH) vitamin D. Vitamin D3 and calcium supplementation increased the concentrations of calcium, phosphorous and decreased the concentrations of parathyroid hormone and alkaline phosphatase. Patients who had low serum 25-hydroxy vitamin D concentrations had more musculoskeletal symptoms which was improved following supplementation (9.14 vs 8.10 p=0.000).
CONCLUSION: Vitamin D3 supplementation significantly improved serum 25-hydroxy vitamin D concentrations and decreased letrozole-induced arthralgia.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  25-hydroxy vitamin D deficiency and insufficiency; Breast cancer patients; Letrozole; Musculoskeletal symptoms

Mesh:

Substances:

Year:  2016        PMID: 27221206     DOI: 10.1016/j.cca.2016.05.020

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

Review 1.  Phytotherapy and Nutritional Supplements on Breast Cancer.

Authors:  C M Lopes; A Dourado; R Oliveira
Journal:  Biomed Res Int       Date:  2017-08-06       Impact factor: 3.411

Review 2.  Prevention and Treatment of Chemotherapy-Induced Alopecia.

Authors:  Alfredo Rossi; Gemma Caro; Maria Caterina Fortuna; Flavia Pigliacelli; Andrea D'Arino; Marta Carlesimo
Journal:  Dermatol Pract Concept       Date:  2020-06-29

Review 3.  Vitamin D, Th17 Lymphocytes, and Breast Cancer.

Authors:  Beata Filip-Psurska; Honorata Zachary; Aleksandra Strzykalska; Joanna Wietrzyk
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

4.  High-dose vitamin D metabolite delivery inhibits breast cancer metastasis.

Authors:  Jiaye Liu; Junyi Shen; Chunyang Mu; Yang Liu; Dongsheng He; Han Luo; Wenshuang Wu; Xun Zheng; Yi Liu; Sunrui Chen; Qiuwei Pan; Yiguo Hu; Yinyun Ni; Yang Wang; Yong Liu; Zhihui Li
Journal:  Bioeng Transl Med       Date:  2021-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.